Remarkable regression of inoperable pancreatic grade 3 neuroendocrine neoplasm after radioligand therapy with [177Lu]Lu-DOTATATE and [90Y]Y‑DOTATATE.

Autor: Durma AD; Department of Endocrinology and Radioisotope Therapy, Military Institute of Medicine – National Research Institute, Warsaw, Poland. adurma@wim.mil.pl, Saracyn M; Department of Endocrinology and Radioisotope Therapy, Military Institute of Medicine – National Research Institute, Warsaw, Poland, Kołodziej M; Department of Endocrinology and Radioisotope Therapy, Military Institute of Medicine – National Research Institute, Warsaw, Poland, Jóźwik-Plebanek K; Department of Endocrinology and Radioisotope Therapy, Military Institute of Medicine – National Research Institute, Warsaw, Poland, Kamiński G; Department of Endocrinology and Radioisotope Therapy, Military Institute of Medicine – National Research Institute, Warsaw, Poland
Jazyk: angličtina
Zdroj: Polish archives of internal medicine [Pol Arch Intern Med] 2023 Nov 29; Vol. 133 (11). Date of Electronic Publication: 2023 Oct 02.
DOI: 10.20452/pamw.16576
Databáze: MEDLINE
načítá se...